354 related articles for article (PubMed ID: 25496033)
1. Farnesoid X receptor antagonizes JNK signaling pathway in liver carcinogenesis by activating SOD3.
Wang YD; Chen WD; Li C; Guo C; Li Y; Qi H; Shen H; Kong J; Long X; Yuan F; Wang X; Huang W
Mol Endocrinol; 2015 Feb; 29(2):322-31. PubMed ID: 25496033
[TBL] [Abstract][Full Text] [Related]
2. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
3. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
4. Activation of farnesoid X receptor increases the expression of cytokine inducible SH2-containing protein in HepG2 cells.
Xu Z; Huang G; Gong W; Zhao Y; Zhou P; Zeng Y; He F
J Interferon Cytokine Res; 2012 Nov; 32(11):517-23. PubMed ID: 22817871
[TBL] [Abstract][Full Text] [Related]
5. Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.
Haga S; Yimin ; Ozaki M
BMC Gastroenterol; 2017 Jan; 17(1):9. PubMed ID: 28086800
[TBL] [Abstract][Full Text] [Related]
6. A Central Role for JNK/AP-1 Pathway in the Pro-Oxidant Effect of Pyrrolidine Dithiocarbamate through Superoxide Dismutase 1 Gene Repression and Reactive Oxygen Species Generation in Hematopoietic Human Cancer Cell Line U937.
Riera H; Afonso V; Collin P; Lomri A
PLoS One; 2015; 10(5):e0127571. PubMed ID: 25996379
[TBL] [Abstract][Full Text] [Related]
7. FXR induces SOCS3 and suppresses hepatocellular carcinoma.
Guo F; Xu Z; Zhang Y; Jiang P; Huang G; Chen S; Lyu X; Zheng P; Zhao X; Zeng Y; Wang S; He F
Oncotarget; 2015 Oct; 6(33):34606-16. PubMed ID: 26416445
[TBL] [Abstract][Full Text] [Related]
8. GW4064, an agonist of farnesoid X receptor, represses CYP3A4 expression in human hepatocytes by inducing small heterodimer partner expression.
Zhang S; Pan X; Jeong H
Drug Metab Dispos; 2015 May; 43(5):743-8. PubMed ID: 25725071
[TBL] [Abstract][Full Text] [Related]
9. FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho.
Fu T; Kim YC; Byun S; Kim DH; Seok S; Suino-Powell K; Xu HE; Kemper B; Kemper JK
Mol Endocrinol; 2016 Jan; 30(1):92-103. PubMed ID: 26505219
[TBL] [Abstract][Full Text] [Related]
10. Mice with hepatocyte-specific FXR deficiency are resistant to spontaneous but susceptible to cholic acid-induced hepatocarcinogenesis.
Kong B; Zhu Y; Li G; Williams JA; Buckley K; Tawfik O; Luyendyk JP; Guo GL
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(5):G295-302. PubMed ID: 26744468
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-Jun N-terminal kinase pathway.
Gupta S; Stravitz RT; Dent P; Hylemon PB
J Biol Chem; 2001 May; 276(19):15816-22. PubMed ID: 11278771
[TBL] [Abstract][Full Text] [Related]
12. The farnesoid X receptor induces fetuin-B gene expression in human hepatocytes.
Murakami T; Walczak R; Caron S; Duhem C; Vidal V; Darteil R; Staels B
Biochem J; 2007 Nov; 407(3):461-9. PubMed ID: 17655523
[TBL] [Abstract][Full Text] [Related]
13. Activation of the farnesoid X receptor attenuates triptolide-induced liver toxicity.
Jin J; Sun X; Zhao Z; Wang W; Qiu Y; Fu X; Huang M; Huang Z
Phytomedicine; 2015 Sep; 22(10):894-901. PubMed ID: 26321738
[TBL] [Abstract][Full Text] [Related]
14. Farnesoid X receptor induces murine scavenger receptor Class B type I via intron binding.
Li G; Thomas AM; Williams JA; Kong B; Liu J; Inaba Y; Xie W; Guo GL
PLoS One; 2012; 7(4):e35895. PubMed ID: 22540009
[TBL] [Abstract][Full Text] [Related]
15. Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells.
Li J; Zhang Y; Kuruba R; Gao X; Gandhi CR; Xie W; Li S
Mol Pharmacol; 2011 Jul; 80(1):191-200. PubMed ID: 21511916
[TBL] [Abstract][Full Text] [Related]
16. GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells.
Xin XM; Zhong MX; Yang GL; Peng Y; Zhang YL; Zhu W
World J Gastroenterol; 2014 Nov; 20(42):15727-35. PubMed ID: 25400456
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
[TBL] [Abstract][Full Text] [Related]
18. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.
Claudel T; Sturm E; Duez H; Torra IP; Sirvent A; Kosykh V; Fruchart JC; Dallongeville J; Hum DW; Kuipers F; Staels B
J Clin Invest; 2002 Apr; 109(7):961-71. PubMed ID: 11927623
[TBL] [Abstract][Full Text] [Related]
19. Farnesoid X receptor (FXR) activation induces the antioxidant protein metallothionein 1 expression in mouse liver.
Wang B; Zhang H; Luan Z; Xu H; Wei Y; Zhao X; Xing M; Huo X; Zhang J; Su W; Guan Y; Zhang X
Exp Cell Res; 2020 May; 390(1):111949. PubMed ID: 32145254
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
Martínez-Fernández P; Hierro L; Jara P; Alvarez L
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]